Literature DB >> 30556621

SNP-SNP and SNP-environment interactions of potentially functional HOTAIR SNPs modify the risk of hepatocellular carcinoma.

Junguo Zhang1, Li Liu1, Zhifeng Lin1, Xiaohui Ji1, Lucheng Pi1, Xinqi Lin1, Nana Tian1, Guiyan Liu1, Qing Liu1, Ziqiang Lin2, Sidong Chen1, Xinfa Yu3, Yanhui Gao1.   

Abstract

HOX transcript antisense intergenic RNA (HOTAIR) has been widely regarded as a functional lncRNA contributing to multiple cancers. However, few studies have examined the effect of single nucleotide polymorphisms (SNPs) in HOTAIR on the occurrence and development of hepatocellular carcinoma (HCC). In this study, three potentially functional HOTAIR SNPs (rs17105613, rs12427129, and rs3816153) were selected using bioinformatic tools. A case-control study including 1262 cases and 1559 controls was conducted to explore the association of HOTAIR SNPs with the risk of HCC in a Southern Chinese population. We found that SNPs rs12427129 and rs3816153 were associated with the risk of HCC in dominant genetic models (CC: CT + TT, adjusted odds ratio (OR) = 0.72, 95% confidence interval (CI) = 0.57-0.90 and GG: GT + TT, adjusted OR = 1.30, 95%CI = 1.08-1.57). Additionally, SNP-environment interactions for rs12427129, rs3816153, and HBsAg status were found to enhance the risk of HCC, with FDR-P as an additive interaction equal to 0.0006 and 0.0144, respectively. In multifactor dimensionality reduction (MDR) analysis, the three-factor model (HBsAg status, rs12427129 and rs3816153) yielded the highest test accuracy of 77.74% (permutation P < 0.001). Interestingly, the effect of rs12427129 and rs3816153 on the risk of HCC could be modified by HBsAg status, while the rs12427129 CT/TT genotype could antagonize the detrimental effect of rs3816153 GT/TT genotype on HCC. Our findings suggest that rs12427129 and rs3816153, including their SNP-SNP and SNP-environment interaction with HBsAg status, potentially play important roles on the susceptibility to HCC.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  HOTAIR; functional annotation; gene-environment interaction; genetic variant; hepatocellular carcinoma

Mesh:

Substances:

Year:  2019        PMID: 30556621     DOI: 10.1002/mc.22955

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  7 in total

1.  Contributions of HOTAIR polymorphisms to the susceptibility of cancer.

Authors:  Hu-Nian Li; Na Deng; Xu Zhao; Jie Liu; Ting He; Xi-Wei Ding
Journal:  Int J Clin Oncol       Date:  2021-02-25       Impact factor: 3.402

2.  Genotype Distribution of Vitamin D Receptor Polymorphisms among Indonesian Patients with Chronic Hepatitis B.

Authors:  Arfianti Arfianti; Athalah Sabillah Sumpena; Fauzia Andrini Djojosugito; Dita Kartika Sari; Ariza Julia Paulina
Journal:  Rep Biochem Mol Biol       Date:  2021-01

Review 3.  Long Non-Coding RNA in the Pathogenesis of Cancers.

Authors:  Yujing Chi; Di Wang; Junpei Wang; Weidong Yu; Jichun Yang
Journal:  Cells       Date:  2019-09-01       Impact factor: 6.600

4.  CMAX3: A Robust Statistical Test for Genetic Association Accounting for Covariates.

Authors:  Zhongxue Chen; Yong Zang
Journal:  Genes (Basel)       Date:  2021-10-28       Impact factor: 4.096

Review 5.  Progress of HOTAIR-microRNA in hepatocellular carcinoma.

Authors:  Bing-Rong Wang; Dong-Xia Chu; Mei-Yu Cheng; Yu Jin; Hao-Ge Luo; Na Li
Journal:  Hered Cancer Clin Pract       Date:  2022-01-29       Impact factor: 2.857

6.  Roles of HOTAIR in lung cancer susceptibility and prognosis.

Authors:  Meng-Meng Ren; Sen Xu; Yu-Bo Wei; Juan-Juan Yang; Ya-Nan Yang; Shan-Shan Sun; You-Jie Li; Ping-Yu Wang; Shu-Yang Xie
Journal:  Mol Genet Genomic Med       Date:  2020-05-11       Impact factor: 2.183

7.  Genetic expression and mutational profile analysis in different pathologic stages of hepatocellular carcinoma patients.

Authors:  Xingjie Gao; Chunyan Zhao; Nan Zhang; Xiaoteng Cui; Yuanyuan Ren; Chao Su; Shaoyuan Wu; Zhi Yao; Jie Yang
Journal:  BMC Cancer       Date:  2021-07-08       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.